Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/HORIZON-THERAPEUTICS-PUBL-18100076/nieuws/Horizon-Therapeutics-plc-kondigt-de-inschrijving-aan-van-de-eerste-patient-in-de-Fase-2-studie-ter-42663664/?utm_source=whatsapp&utm_medium=social&utm_campaign=share